Ip Licence Agreement Sample Contracts
IP licence agreement: of technical product in a single industry or marketIp Licence Agreement • September 28th, 2020
Intellectual Property Licence Agreement for UK Centres offering Higher National Qualifications and Programmes based on Pearson’s BTEC Specifications Version: January 2019Ip Licence Agreement • April 30th, 2019 • England and Wales
A Pearson is the owner of Higher National Certificate and Higher National Diploma registered trade marks and of BTEC Higher National qualifications.
ContractIp Licence Agreement • October 6th, 2021 • Immix Biopharma, Inc. • Pharmaceutical preparations • California
[*] Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
IP LICENCE AGREEMENT BIONOMICS LIMITED CARINA BIOTECH PTY LTDIp Licence Agreement • November 22nd, 2021 • Bionomics Limited/Fi • Pharmaceutical preparations
IP Licence AgreementIp Licence Agreement • December 6th, 2018
ContractIp Licence Agreement • May 9th, 2017
IP Licence Agreement for Higher Education Institutions offering Higher National Qualifications and Programmes based on Pearson’s Specifications
MY FIZIQ LTD ACN 602 111 115 (MyFiziq) and BODY COMPOSITION TECHNOLOGIES PTY LIMITED ACN 620 646 531 (Company) IP LICENCE AGREEMENT THIS AGREEMENT is made the 22 day of September 2017 BETWEEN MYFIZIQ LTD (ACN 602 111 115) of Suite 5, 71-73 South Perth...Ip Licence Agreement • August 26th, 2021 • Advanced Human Imaging LTD • Services-prepackaged software • Western Australia
AMENDED AND RESTATED IP LICENCE AGREEMENT dated as of October 1, 2025 by and between BIOCRYST PHARMACEUTICALS, INC., as the Licensor, and BIOCRYST IRELAND LIMITED, as the LicenseeIp Licence Agreement • October 1st, 2025 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
This AMENDED AND RESTATED IP LICENCE AGREEMENT (this “Agreement”), dated as of October 1, 2025 (the “Effective Date”), is entered into by and between BioCryst Pharmaceuticals, Inc., a Delaware corporation (the “Licensor”) and BioCryst Ireland Limited, a corporation organized under the laws of the Republic of Ireland (the “Licensee”) (each, a “Party,” and collectively, the “Parties”).
IP Licence AgreementIp Licence Agreement • August 27th, 2024
ContractIp Licence Agreement • April 20th, 2022